Hostname: page-component-7bb8b95d7b-s9k8s Total loading time: 0 Render date: 2024-09-14T05:01:57.894Z Has data issue: false hasContentIssue false
  • English
  • Français

Parvovirus B19-Antibody Serosurvey in 500 Developmentally Disabled Subjects

Published online by Cambridge University Press:  02 January 2015

Ghan-Shyam Lohiya ,
Wayne Hogrefe ,
Lilia Tan-Figueroa  and
Shirley Caires
Get access Rights & Permissions [Opens in a new window]

Abstract

Sera of 500 residents were screened for parvovirus B19 immunoglobulin M (IgM) and immunoglobulin G (IgG) by enzyme-linked immunosorbent assay. Positive IgM and equivocal IgG or IgM results were confirmed by immunofluorescent antibody and Western blot. IgM was detected in 13 sera (2.6%), and IgG was detected in 285 (57%). Records of IgM-positive residents contained no evidence of erythema infectiosum or polyarthropathy.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 18 , Issue 5 , May 1997 , pp. 340 - 342
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Torok, T. Parvovirus B19 and human disease. Adv Intern Med 1992;37:431–455.Google ScholarPubMed
2. Kerr, J. Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis 1996;15:10–29.CrossRefGoogle ScholarPubMed
3. Lohiya, G, Stewart, K, Perot, K. Parvovirus B19 outbreak in a developmental center. Am J Infect Control 1995;23:373–376.CrossRefGoogle Scholar
4. Adler, S, Manganello, A, Koch, W. Risk of human parvovirus B19 infections among school and hospital employees. J Infect Dis 1993;168:361–368.CrossRefGoogle ScholarPubMed
5. Bell, L, Naides, S, Stoffman, P. Human parvovirus B19 infection among hospital staff. N Engl J Med 1989;321:485–491.CrossRefGoogle ScholarPubMed
6. Rice, P, Cohen, B. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays. Epidemiol Infect 1996;116:331–338.CrossRefGoogle ScholarPubMed
7. Bruu, A, Nordbo, S. Evaluation of five tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol 1995;33:1363–1365.CrossRefGoogle ScholarPubMed
8. Gray, J, Roth, C, Swygart, C, Desselberger, U. Human parvovirus B19 serology with recombinant VP1 and VP2 antigens. Clin Diagn Virol 1994;2:331–341.CrossRefGoogle ScholarPubMed
9. Anderson, L. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987;6:711–718.CrossRefGoogle ScholarPubMed
10. Garner, JS, the Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Guideline for isolation precautions in hospitals, part II: recommendations for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:60–80.CrossRefGoogle Scholar